Key result
Perindopril A improved vascular stiffness in hypertensive patients with and without diabetes (SI decreased to 9.8 and 9.25 m/s), but microvascular endothelial function did not improve in diabetics.
Why the study?
The study was conducted to investigate changes in morphological and functional markers of vascular remodeling during 12-month perindopril A administration in arterial hypertension patients with and without concomitant type 2 diabetes mellitus.
Does perindopril A 10 mg/day improve morphological and functional markers of vascular remodeling in patients with arterial hypertension with and without type 2 diabetes mellitus?
Cohort (n=62)
Does perindopril A 10 mg/day improve morphological and functional markers of vascular remodeling in patients with arterial hypertension with and without type 2 diabetes mellitus?
Prolonged therapy with perindopril A improves vascular morphological parameters in hypertensive patients, but those with concomitant type 2 diabetes exhibit more severe endothelial dysfunction that does not improve with this treatment.
Perindopril may improve vascular markers more in hypertension alone than with diabetes; leaves open differential endothelial effects and need for outcome trials.
Objective Investigate the dynamics of morphological and functional markers of vascular remodeling in patients with arterial hypertension (AH), including those with concomitant type 2 diabetes mellitus (DM2), during 12-month administration of perindopril A.Material and Methods The study included patients with grade I-II AH, with and without DM2 (30 and 32 patients, respectively), who underwent outpatient correction of initially ineffective antihypertensive therapy and administration of perindopril A, 10 mg/day. Morphological and functional parameters of vascular remodeling were evaluated in all patients at baseline and at 12 months using photoplethysmography. Stiffness index (SI) and phase shift (PS) were measured in large vessels. Reflection index (RI) and occlusion index (OI) were measured in microvessels. Computed nailfold videocapillaroscopy was used to determine capillary density (CD) at rest (CDr), CD during venous occlusion test (CDvo), and CD during reactive hyperemia test (CDrh). Data are medians [interquartile range].Results After 12-month administration of perindopril A, the morphological and functional parameters of vascular remodeling in AH patients without DM2 significantly improved at all vascular levels. SI decreased to 9.25 [7.8; 10.93 ] m/s and PS increased to 7.4 [5.6; 9.05] ms. In microvasculature, a statistically significant reduction was observed in RI, 31 [27; 36.5]%, and an increase was observed in OI, which characterizes endothelium function, 1.75 [1.68; 1.9]. Capillary CDr significantly increased to 40.5 [34.93; 46] cap/mm2, as did CDvo and CDrh. At the same time, in the group of patients with AH and DM2, a significant improvement was observed for the large vessels. SI decreased to 9.8 [9.08; 10.58] m/s, and PS increased to 6.95 [5.13; 10.08]. The RI index, reflecting the structural condition of arterioles, significantly decreased to 34 [25.9; 45.53]%, and the OI index, characterizing endothelial function, did not change significantly, 1.4 [1.3; 1.6]. Capillary CDr significantly increased to 31.55 [27.68; 34.7 ] cap/mm2; however, CDvo and CDrh did not change significantly. Renal function improved in both groups.Conclusion Both groups demonstrated improvement of morphological parameters at all levels of the arterial bed. However, patients with AH and concomitant DM2 showed no improvement of the endothelial function of arterioles and capillaries compared to improvement in AH patients without DM2. This reflected the more severe endothelial dysfunction present in AH patients with DM2.
No takes yet. Share an insight, caveat, or question.
Danilogorskaya et al. (2020) conducted a cohort in Arterial hypertension with and without type 2 diabetes mellitus (n=62). Perindopril A vs. Baseline was evaluated on Morphological and functional parameters of vascular remodeling. Perindopril A improved vascular stiffness in hypertensive patients with and without diabetes (SI decreased to 9.8 and 9.25 m/s), but microvascular endothelial function did not improve in diabetics.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: